Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management

Contributed by: Business Wire

Logo

Images

David Ferrando, Ferrer's Chief Marketing and Market Access Officer and Jorge Cuneo, Ferrer's Chief Medical Officer, at the IMPAHCT opening session.

Business Wire embedded0

Tags

Research

Hospitals

Cardiology

Biotechnology

Other Health

Health

Pharmaceutical

Other Science

Science

IMPAHCT

More Like This

Pulmonary Hypertension Awareness Month: Two European Studies Highlight the Urgency of Patients and Experts to Improve the Diagnosis and Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease

Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)

International Research Collaboration Aims to Personalise Prevention and Treatment of Cardiovascular Diseases

Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee

PR Newswire associated0

Recor Medical Champions Global Action on World Hypertension Day: Early Intervention and Continued Innovation Crucial in Tackling This Silent Killer Impacting Billions Worldwide

Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease

PR Newswire associated0

ISTH Releases Evidence-Based Clinical Practice Guideline for Hemophilia Treatment

Pulnovo Medical Announces Closing of Nearly $100 Million Series C Financing